Cliff Asness’s AstraZeneca AZN Stock Holding History

Cliff Asness’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75M	Buy	400,938 +31,136	+8%	+$5.86M	0.03%	698
2026 Q1	$71.9M	Buy	369,802 +313,822	+561%	+$60.5M	0.03%	616
2025 Q4	$10.3M	Buy	55,980 +13,588	+32%	+$2.38M	0.01%	1204
2025 Q3	$6.5M	Buy	42,392 +15,420	+57%	+$2.33M	﹤0.01%	1303
2025 Q2	$3.77M	Buy	26,972 +8,221	+44%	+$1.15M	﹤0.01%	1442
2025 Q1	$2.76M	Buy	18,751 +5,845	+45%	+$846K	﹤0.01%	1435
2024 Q4	$1.69M	Buy	12,906 +3,474	+37%	+$486K	﹤0.01%	1623
2024 Q3	$1.47M	Buy	9,432 +2,589	+38%	+$418K	﹤0.01%	1649
2024 Q2	$1.07M	Buy	6,843 +3,621	+112%	+$545K	﹤0.01%	1724
2024 Q1	$437K	Buy	3,222 +670	+26%	+$88.7K	﹤0.01%	2003
2023 Q4	$344K	Buy	2,552 +182	+8%	+$23.7K	﹤0.01%	2019
2023 Q3	$321K	Buy	+2,370	New	+$324K	﹤0.01%	1991
2014 Q3	–	Sell	-1,186,418	Closed	-$88.2M	–	2513
2014 Q2	$88.2M	Buy	+1,186,418	New	+$85.8M	0.24%	101

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cliff Asness's AZN Position: Q2 2026 in Review

Cliff Asness increased its AstraZeneca (AZN) stake by 8.4% in Q2 2026, buying an estimated $5.86M and bringing the position to 400,938 shares worth $75M. The position accounts for 0.03% of the portfolio, ranked #698.

Cliff Asness first reported a position in AZN in Q2 2014 and has held it in 13 quarters since. The position peaked at $88.2M in Q2 2014. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Cliff Asness held 400,938 shares of AstraZeneca worth $75M as of Q2 2026.
Cliff Asness bought 31,136 AstraZeneca shares in Q2 2026, an estimated $5.86M.
AstraZeneca made up 0.03% of Cliff Asness's portfolio in Q2 2026, its #698 holding.
Cliff Asness first reported a position in AstraZeneca in Q2 2014 and has held it in 13 quarters since.
Cliff Asness's AstraZeneca position peaked at $88.2M in Q2 2014.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.